D-0541-2025 Class II Ongoing

Recalled by Cipla USA, Inc. — Warren, NJ

Recall Details

Product Type
Drugs
Report Date
July 30, 2025
Initiation Date
June 30, 2025
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
13,680 ampoules

Product Description

Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton)

Reason for Recall

Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.

Distribution Pattern

Distributed Nationwide in the USA

Code Information

Batch # 4IA0505, Exp 09/31/2026